Akums Drugs & Pharmaceuticals (AKUMS.NS) Earnings Analysis
Akums Drugs & Pharmaceuticals (AKUMS.NS) next reports earnings on 2026-08-07, consensus EPS 6.1 INR. It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 41.94.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AKUMS.NS next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 6.1 INR |
| Revenue estimate | 11.65B |
AKUMS.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 5.5 INR | n/a | n/a | n/a |
| 2026-02-13 | 4.33 INR | 4.1 INR | +5.6% | Beat |
| 2025-11-13 | 2.66 INR | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
AKUMS.NS valuation and analyst view
| Trailing P/E | 41.94 |
|---|---|
| Trailing EPS | 16.678 INR |
| Price / book | 3.23 |
| Dividend yield | 0.43% |
| Market cap | 106.56B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Akums Drugs & Pharmaceuticals (AKUMS.NS)'s next earnings date?
Akums Drugs & Pharmaceuticals is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 6.1 INR and revenue estimate of 11.65B.
Did AKUMS.NS beat earnings last quarter?
Consensus estimate data was not available for AKUMS.NS's 2026-05-14 report.
What is AKUMS.NS's earnings track record?
Over the last 1 reported quarters with consensus data, AKUMS.NS beat estimates 1 times (100%).
What is AKUMS.NS's current P/E ratio and EPS?
AKUMS.NS trades at a trailing P/E of 41.94 on trailing EPS of 16.678191193866947 INR.
What do analysts rate AKUMS.NS?
AKUMS.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.